Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.jaci.2020.05.002 http://scihub22266oqcxt.onion/10.1016/j.jaci.2020.05.002 32437739!7211718!32437739     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Allergy+Clin+Immunol 2020 ; 146 (1): 213-215 Nephropedia Template TP {{tp|p=32437739|t=2020. Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease |pdf=|usr=}}{{32437739}} gab.com Text Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease JO: J Allergy Clin Immunol http://www.kidney.de/pget.php?&tw=1&pmid=32437739 #FOAvip ä Twit Text FOAVip Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease ????J Allergy Clin Immunol http://www.kidney.de/pget.php?&tw=1&pmid=32437739 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32437739 #FOAvip English Wikipedia <ref>{{Cite pmid|32437739}}</ref> Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease #MMPMID32437739 Pontali E; Volpi S; Antonucci G; Castellaneta M; Buzzi D; Tricerri F; Angelelli A; Caorsi R; Feasi M; Calautti F; Castagnola E; Rollandi GA; Ravelli A; Cassola G; Gattorno M J Allergy Clin Immunol 2020[Jul]; 146 (1): 213-215 PMID32437739show ga ä |Administration, Intravenous[MESH] |Adult[MESH] |Antirheumatic Agents/*administration & dosage[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |Coronavirus Infections/complications/*drug therapy[MESH] |Female[MESH] |Humans[MESH] |Interleukin 1 Receptor Antagonist Protein/*administration & dosage[MESH] |Male[MESH] |Middle Aged[MESH] |Pandemics[MESH] |Pneumonia, Viral/complications/*drug therapy/virology[MESH] |SARS-CoV-2[MESH]Safety and efficacy of early high-dose IV anakinra in severe COVID-19 (epmc).pdf DeepDyve Pubget Overpricing